Graphene Flagship of Gothenburg at MEDICA 2017 in Düsseldorf -- MEDICA - World Forum for Medicine

Graphene Flagship

Kemivägen 1, 41296 Gothenburg
Sweden

Hall map

MEDICA 2017 hall map (Hall 15): stand C43

Fairground map

MEDICA 2017 fairground map: Hall 15

Contact

Eugenia Vranjancu

Head of Dissemination

Phone
+46 31 772 32 84

Email
eugenia.vranjancu@chalmers.se

Visit us

Hall 15 / C43

15.11.2017

Topic

Download

11:30 - 12:30

Guided tour for press on Graphene Biomedical Technologies at the Graphene Flagship booth

No registration required.

More Less

14:30 - 15:00

Talk at the COMPAMED Suppliers Forum by DeviceMed

Graphene for Neural Interfaces and Biomedical Technologies by Jose Antonio Garrido/Graphene Flagship (hall 8b, stand G40)

More Less

16.11.2017

Topic

Download

10:15 - 17:00

Graphene Connect workshop - Biomedical Technologies

The Graphene Connect workshop will take place in Hall 8b on the first floor in the conference room 814A.
Attendance is free of charge.

More Less

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.01  General Diagnostics

General Diagnostics

  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.03  Implants and protheses
  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.10  Stimulation equipment for diagnostics / therapy

Stimulation equipment for diagnostics / therapy

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.05  Electrodes and biosensors

Electrodes and biosensors

Our products

Product category: General Diagnostics

Brain Computer Interface

The flexible and lightweight nature of graphene, coupled with its high conductivity, makes it an excellent material for bridging the brain computer interface for monitoring brain activity in a non-invasive manor. Guger Technologies - g.tec (Austria) is using graphene as an electrode to measure the electrical signals in the brain, and has been able to produce a device with real time processing that is also able to produce a stronger output signal.

More Less

Product category: Implants and protheses, Stimulation equipment for diagnostics / therapy

Retinal prosthesis interface

ICN2, The Paris Vision Institute, and Pixium Vision are exploring the use of graphene technology in retinal prostheses that are being developed to partially recover the sight of people that have lost the functionality of the photosensitive cells in the retina. Research shows that graphene provides an efficient interface
for communication between the retina prosthesis and nerve tissue, which can be eventually translated into an improved quality of the images perceived by the patient’s brain.

More Less

Product category: Implants and protheses, Electrodes and biosensors

Prosthetic hand

The robotic prosthetic hand is controlled by a wearable sensor in the form of a bracelet made by a cellulose and graphene composite, developed by Istituto Italiano di Tecnologia – IIT (Italy). Current commercially available electrodes are big, heavy and invasive whereas the graphene-based wearable sensor is lightweight, flexible and comfortable to wear, which is increasing the user experience for the patient.

More Less

Product category: Stimulation equipment for diagnostics / therapy, Electrodes and biosensors

Brain sensor

Researchers from ICN2 and CNM have used the unique properties of graphene to develop electronic sensors for brain monitoring. They are using graphene devices fabricated on ultra-flexible polymeric substrates that adapts to the brain morphology to detect electrical signals within the brain. This could be used to control the movement of a robotic arm or for early detection of an epileptic event.

More Less

Company news

Date

Topic

Download

Nov 8, 2017

GRAPHEN - DAS MATERIAL MIT DEM POTENZIAL DIE ZUKUNFT BIOMEDIZINISCHER TECHNOLOGIEN ZU VERÄNDERN

Das Graphene Flagship, die EU-weite Forschungsinitiative für Graphen und andere verwandte Nanomaterialien, präsentiert sich mit innovativen biomedizinischen Technologien auf der MEDICA 2017, der wichtigsten medizinischen Fachmesse der Welt. Mit mehr als 130.000 Besuchern und 5.100 Ausstellern, die vom 13.-16. November 2017 in Düsseldorf erwartet werden, ist die MEDICA die ideale Plattform für das Graphene Flagship, seine innovativen Graphen-basierten Lösungen für den Gesundheitsbereich vorzustellen.

Graphen und andere verwandte Nanomaterialien besitzen einzigartige Eigenschaften, wie zum Beispiel eine große Oberfläche, eine hohe Elektronenmobilität sowie eine flexiblere Oberflächenfunktionalisierung und ebnen damit den Weg für neuartige biomedizinische Diagnose- und Therapieverfahren. Die Oberfläche von Graphen stellt beispielsweise eine ausgezeichnete Plattform für die Wirkstoffabgabe bei Medikamenten dar, während sich seine hohe Leitfähigkeit positiv bei der Anwendung in Biosensoren auswirkt. Aufgrund der Aufrechterhaltung der Leitfähigkeit des Materials bei der Herstellung von Scaffolds, eignet sich Graphen auch für die Verwendung im Tissue Engineering. Neue Forschungsergebnisse zeigen außerdem, dass sich Graphen auch mit Polymeren verarbeiten lässt und dadurch in der Herstellung elektromechanischer Sensoren und Hirnimplantate Einsatz finden könnte.

Professor Andrea C. Ferrari, Science and Technology Officer und Vorstandsvorsitzender des Graphene Flagship gab an, dass „Gesundheit, Umwelt und biomedizinische Anwendungen einen Teil der Roadmap für Graphen und ähnliche Materialien darstellen. Wir freuen uns, Ärzte, medizinisches Fachpersonal und Unternehmen mit innovativen Instrumenten bekannt zu machen. Dies ist ein weiterer Schritt in der Entwicklung neuartiger Lösungen für biomedizinische Zwecke, die durch Graphen und ähnliche Materialien ermöglicht werden.“

Das Graphene Flagship wird auf der MEDICA 2017 vier Beispiele für innovative, biomedizinische Technologien, die sich die Vorteile von Graphen zu Nutzen machen, präsentieren. Am Graphene Flagship-Stand erhalten Besucher nicht nur Einblicke in die neuesten Forschungsergebnisse, sondern können sich auch mit führenden Experten des Graphene Flagship austauschen.

Zwei dieser Exponate werden vom Katalanischen Institut für Nanowissenschaften und Nanotechnologie (ICN2), einem Partner des Graphene Flagship, vorgestellt: Es handelt sich dabei einerseits um einen Graphen-Sensor, der elektrische Aktivität im Gehirn zur Früherkennung neurologischer Ereignisse, wie z.B. epileptischer Anfälle, ermittelt werden kann und andererseits um ein Retinaimplantat, das als optische Prothese bei Menschen, die ihr Augenlicht verloren haben, dient. Ein weiterer Demonstrator, der am Stand des Graphene Flagship gezeigt wird, ist ein vollständig funktionsfähiger Roboterarm, gesteuert mit Hilfe von Graphen-Sensoren, der vom Istituto Italiano di Tecnologia (IIT) in Zusammenarbeit mit der italienischen Versicherungsanstalt gegen Arbeitsunfälle (INAIL) entwickelt wurde. Der Graphene Flagship-Partner Guger Technologies (g.tec) mit Sitz in Österreich präsentiert eine Computerschnittstelle zum Gehirn, die mit Graphenelektroden ausgestattet ist und die Hirnaktivität messen kann.
Graphen und andere verwandte Nanomaterialien werden auch im Konferenzprogramm der MEDICA thematisiert. Jose Antonio Garrido von ICN2 erläutert beim Suppliers Forum von DeviceMed im Rahmen der COMPAMED den aktuellen Stand in Bezug auf neuronale Schnittstellen und biomedizinische Technologien.

„Wir bringen Technologien, Vorträge und die Möglichkeit zum Netzwerken zur MEDICA um auf die Potenziale von Graphen und ähnlichen Materialien aufmerksam zu machen und Endverbraucher anzusprechen. Es ist uns wichtig, neue Funktionalitäten für die Praxis bereitzustellen, die durch die Verwendung neuer Materialien ermöglicht werden“, so Jose Antonio Garrido.

Darüber hinaus wird das Graphene Flagship auf der MEDICA einen seiner Graphene Connect Workshops veranstalten. Bei dieser eintägigen Veranstaltung treffen sich führende Experten aus Industrie und Wissenschaft zu Vorträgen, Gesprächen und zum Knüpfen von Kontakten. Die behandelten Themen reichen von Möglichkeiten für den Einsatz von Graphen in Biosensoren, Implantaten und bioelektronischen Geräten bis hin zu mobilen Geräten und neuronalen Schnittstellen.

Dr. Kari Hjelt, Innovationsmanager des Graphene Flagship, leitet den Graphene Connect Workshop. Ihm zufolge „zielt Graphene Connect darauf ab, innovative Projekte innerhalb und außerhalb des Graphene Flagship-Konsortiums zu fördern. Die Zusammenarbeit zwischen biotechnologischer Forschung und Industrie ist unerlässlich, wenn wir uns innovative Ziele setzen wollen; außerdem müssen die Forschungsvorhaben an wirtschaftlich vielversprechenden Anwendungen ausgerichtet werden. Biotechnologie steht beim Graphene Flagship im Mittelpunkt des Interesses und wir freuen uns über die Begeisterung, die unsere Veranstaltung Graphene Connect bei der MEDICA 2017 bereits im Vorfeld ausgelöst hat.”

Liste der Technologie-Exponate des Graphene Flagship und seiner Ausstellungspartner

  • Retinaprothesen-Schnittstelle - Katalanisches Institut für Nanowissenschaften und Nanotechnologie – ICN2 (Spanien)
  • Gehirnsensor - Katalanisches Institut für Nanowissenschaften und Nanotechnologie – ICN2 (Spanien)
  • Roboterarm - Fondazione Istituto Italiano di Tecnologia – IIT (Italien)
  • Gehirn-Computer-Schnittstelle – Guger Technologies – g.tec (Österreich)

More Less

Nov 8, 2017

INNOVATIVE BIOMEDICAL TECHNOLOGIES FROM THE GRAPHENE FLAGSHIP AT MEDICA 2017

The Graphene Flagship, EU’s biggest research initiative into graphene and related materials, will present innovative biomedical technologies at the largest medical trade fair in the world – MEDICA 2017. With more than 130,000 professional visitors and 5,100 exhibitors expected from 13-16 November 2017 in Dusseldorf, Germany, MEDICA promises to be a wide-reaching platform for the Graphene Flagship to showcase its graphene based novel healthcare solutions.

Graphene and related materials are paving the way for novel biomedical diagnoses and treatments thanks to their unique properties such as high surface area, electron mobility and surface functionalization- all favourable for biomedical technologies. For instance, the surface area of graphene makes an excellent platform for drug delivery and the conductivity allows for effective biosensors. The ability of graphene to be made into scaffolds whilst maintaining the inherent conductivity can be used in tissue engineering. New research has shown that graphene can also be incorporated with a polymer to make electromechanical sensors and deep brain implants.

Professor Andrea C. Ferrari, Science and Technology Officer of the Graphene Flagship and Chair of its Management Panel said “Health, Environment and Bio-Medical applications are part of the roadmap for graphene and related materials. We are excited to present innovative devices to medical professionals and companies. This is yet another step towards the full development of novel biomedical solutions enabled by graphene and related materials.”

At MEDICA 2017 the Graphene Flagship will be showcasing four demonstrators of innovative biomedical technologies. The booth allows visitors to not only get an insight into the latest graphene research on biomedical technologies but gives an opportunity for discussion with leading experts from the Graphene Flagship.

Graphene Flagship partner Catalan Institute of Nanoscience and Nanotechnology (ICN2) will be displaying two of these demonstrators: a graphene sensor able to detect the electrical activity of the brain providing early detection for neurological events such as epileptic seizures; and a retinal implant which can serve as optical prostheses for people who have lost their sight. A fully functional robotic hand controlled by graphene sensors will be demoed by Flagship Partner Istituto Italiano di Tecnologia (IIT); IIT is developing this research project with INAIL, the Italian National Institute for Insurance against Accidents at Work. The Graphene Flagship Partner Guger Technologies (g.tec), headquartered in Austria, will also present a brain computer interface containing graphene electrodes capable of measuring brain activity.

Graphene will be prominently featured within the MEDICA conference program with Jose Antonio Garrido from ICN2 talking during the COMPAMED suppliers forum by DeviceMed. Garrido will discuss the current state of the art when it comes to graphene for neural interfaces and biomedical technologies.
“We are bringing technology, talks and networking opportunities to MEDICA to make an impact and meet end users. What we want is to bring new functionalities to the field which will come with novel materials.” said Jose Antonio Garrido.

Also at MEDICA the Graphene Flagship will be running one of its Graphene Connects, focused on Biomedical Technologies. This one-day event will bring together key experts from industry and academia with a series of talks and networking opportunities. It will cover topics ranging from opportunities for graphene in biosensors, implants and bioelectronics to wearables, health and neural interfaces.

Dr Kari Hjelt, Head of Innovation for the Graphene Flagship, who will be leading the Graphene Connect, said “Graphene Connect aims to foster innovation projects both within and outside the Graphene Flagship consortium. The collaboration with biotechnology research and industry is needed in order to set the targets for innovations and to direct research efforts towards the most commercially promising applications. Biotechnology is one of the focus areas for the Graphene Flagship and we are excited to see the enthusiasm that the Graphene Connect event at MEDICA 2017 has created.”

List of Graphene Flagship technology exhibits and exhibiting partners
  • Retinal Prosthesis Interface - Catalan Institute of Nanoscience and Nanotechnology – ICN2 (Spain)
  • Brain Sensor - Catalan Institute of Nanoscience and Nanotechnology – ICN2 (Spain)
  • Robotic Arm - Istituto Italiano di Tecnologia – IIT (Italy)
  • Brain Computer Interface – g.tec (Austria)

More Less

Aug 18, 2017

Graphene in Biomedical Technologies

As the demand for healthcare services continues to increase, so does the demand for novel healthcare solutions. These solutions should be more effective, cost less, prevent disease as well as cure it, and should be equally effective throughout the world. Graphene is paving the way for novel diagnosis and treatments, thanks to its unique properties, such as high surface area, electron mobility and functionalisation potential, all favourable for biomedical technologies.

For instance, the surface area of graphene makes an excellent platform for drug delivery and the conductivity makes for effective biosensors. The ability of graphene to be made into scaffolds whilst maintaining the inherent conductivity can be put to use in tissue engineering. New research has shown that graphene can be incorporated with a polymer to make very sensitive electromechanical sensors and that it can be used to make better deep brain implants.

More Less

About us

Company details

The Graphene Flagship was launched by the European Union in 2013 as part of its largest research initiative ever. With a budget of €1 billion it represents a new form of joint, coordinated research initiative on an unprecedented scale. The overall goal of the Graphene Flagship is to take graphene from the realm of academic laboratories into European society, facilitating economic growth and creating new jobs, in the space of ten years. Through a combined academic-industrial consortium consisting of more than 150 partners in over 20 European countries, the research effort covers the entire value chain, from materials production to components and system integration, and targets a number of specific goals that exploit the unique properties of graphene.

More Less

Company data

Foundation

2013

Area of business
  • Electromedical equipment / Medical Technology
  • Diagnostics
  • Information and Communication Technology

Company information as a PDF file